西藏药业涨5.00%创近9个月新高核心产品优势与政策红利驱动

智选洞察2025-07-31

西藏药业（600211）今日盘中表现强势，截至10点00分，股价报43.44元，上涨5.00%，创近9个月以来新高。资金面博弈与板块轮动共振西藏药业近期股价波动主要受资金面与市场情绪共振影响。截至7月30日，主力资金连续两日累计净流入超5700万元，单日量比从0.64倍骤增至1.91倍，显示短线资金博弈加剧。板块轮动效应显著，医药生物板块近一个月资金净流出47.6亿元，电子、通信等成长板块吸金明显...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555795074?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-31 10:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555795074","market":"sh","top_or_hot":-1,"title":"西藏药业涨5.00%创近9个月新高 核心产品优势与政策红利驱动","media":"智选洞察","content":"<div>\n<p>西藏药业（600211）今日盘中表现强势，截至10点00分，股价报43.44元，上涨5.00%，创近9个月以来新高。资金面博弈与板块轮动共振西藏药业近期股价波动主要受资金面与市场情绪共振影响。截至7月30日，主力资金连续两日累计净流入超5700万元，单日量比从0.64倍骤增至1.91倍，显示短线资金博弈加剧。板块轮动效应显著，医药生物板块近一个月资金净流出47.6亿元，电子、通信等成长板块吸金明显...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731100125a6ca956d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>西藏药业涨5.00%创近9个月新高 核心产品优势与政策红利驱动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n西藏药业涨5.00%创近9个月新高 核心产品优势与政策红利驱动\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-31 10:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731100125a6ca956d&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>西藏药业（600211）今日盘中表现强势，截至10点00分，股价报43.44元，上涨5.00%，创近9个月以来新高。资金面博弈与板块轮动共振西藏药业近期股价波动主要受资金面与市场情绪共振影响。截至7月30日，主力资金连续两日累计净流入超5700万元，单日量比从0.64倍骤增至1.91倍，显示短线资金博弈加剧。板块轮动效应显著，医药生物板块近一个月资金净流出47.6亿元，电子、通信等成长板块吸金明显...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731100125a6ca956d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0033","symbol_name":"西藏振兴","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731100125a6ca956d&s=b","article_id":"2555795074","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731100125a6ca956d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555795074","pubTimestamp":1753927275,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"西藏药业今日盘中表现强势，截至10点00分，股价报43.44元，上涨5.00%，创近9个月以来新高。资金面博弈与板块轮动共振西藏药业近期股价波动主要受资金面与市场情绪共振影响。核心产品优势与政策红利双轮驱动西藏药业中长期逻辑仍锚定心血管领域核心产品竞争力。2024年公司净利润同比增长31%至10.51亿元，自有产品收入占比达99.74%，构筑业绩护城河。中信证券指出，公司有望受益医疗设备更新政策红利，2024年ROE达6.74%超行业水平。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600211":"西藏药业","BK0033":"西藏振兴","BK0239":"医药制造"},"translate_title":"Tibet Pharmaceutical rose 5.00%, hitting a new high in nearly 9 months, driven by core product advantages and policy dividends","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600211":1},"content_text":"西藏药业（600211）今日盘中表现强势，截至10点00分，股价报43.44元，上涨5.00%，创近9个月以来新高。资金面博弈与板块轮动共振西藏药业近期股价波动主要受资金面与市场情绪共振影响。截至7月30日，主力资金连续两日累计净流入超5700万元，单日量比从0.64倍骤增至1.91倍，显示短线资金博弈加剧。板块轮动效应显著，医药生物板块近一个月资金净流出47.6亿元，电子、通信等成长板块吸金明显，压制板块整体动能。此外，医疗设备集采预期反复触发机构调仓需求，叠加生物制品板块年内涨幅落后大盘5.2个百分点，资金配置意愿呈现阶段性波动。核心产品优势与政策红利双轮驱动西藏药业中长期逻辑仍锚定心血管领域核心产品竞争力。2024年公司净利润同比增长31%至10.51亿元，自有产品收入占比达99.74%，构筑业绩护城河。当前动态市盈率13.90倍（截至7月31日），显著低于行业均值，叠加4.50%股息率凸显估值性价比。中信证券指出，公司有望受益医疗设备更新政策红利，2024年ROE达6.74%超行业水平。技术面显示，站稳41.24元压力位后，股价存在挑战45元关口的可能，但需警惕集采政策对心血管产品利润率的潜在冲击。后市走势或呈现震荡上行格局，政策端变化与研发进展将成为关键变量。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555795074","isCrawlerRequest":true}

西藏药业涨5.00%创近9个月新高 核心产品优势与政策红利驱动

精彩评论

西藏药业涨5.00%创近9个月新高核心产品优势与政策红利驱动